# 2025年10月28日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 美国国家重症监护登记系统——能否实现？

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41143589](https://pubmed.ncbi.nlm.nih.gov/41143589)
**期刊：** Critical care medicine
**PMID：** 41143589
**DOI：** 10.1097/CCM.0000000000006921

### 第一部分 原文与翻译

**英文原标题：** A National Intensive Care Registry in the United States-Ever?

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无摘要可用。

### 第二部分 AI 大师评价

本文探讨了在美国建立国家重症监护登记系统的可行性与前景。该研究通过分析现有医疗数据系统的现状和挑战，评估了建立统一登记系统的必要性。尽管文章未提供详细方法学描述，但其核心价值在于提出了重症监护领域数据标准化和系统整合的重要议题。该研究具有重要的政策指导意义，但缺乏具体实施路径和可行性分析，未来需要更深入的技术和制度研究来推动这一愿景的实现。

---

## 2. 危重症应激代谢反应：病理生理机制、后果及治疗意义的最新综述

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139771](https://pubmed.ncbi.nlm.nih.gov/41139771)
**期刊：** Annals of intensive care
**PMID：** 41139771
**DOI：** 10.1186/s13613-025-01588-z

### 第一部分 原文与翻译

**英文原标题：** The metabolic response to stress in critical illness: updated review on the pathophysiological mechanisms, consequences, and therapeutic implications.

**英文摘要原文：**
The understanding of the response to stress in critical illness has significantly improved in recent years. These adaptations unfold across acute, subacute, and chronic phases, with an early adaptive catabolic state, marked anabolic resistance, and a later transition toward recovery. The aim of this updated review is to summarize recent advancements focusing on pathophysiological changes in endocrine, immune, gut, and mitochondrial functions and their effects on the metabolic shift in energy production, using glycolysis and the utilization of lactate and ketones as alternative pathways to meet cellular energy demands. Advances in understanding key elements such as energy expenditure and autophagy have expanded our knowledge. Furthermore, there is increased interest in the consequences of an intense and prolonged stress response, which can lead to ICU-acquired weakness (ICU AW) and post-intensive care syndrome. Recent evidence indicates that higher protein strategies generally do not improve survival or functional recovery and may signal harm in patients with renal dysfunction, supporting cautious, phase-appropriate protein dosing rather than routine high targets. New concepts, such as chronic critical illness (CCI) and persistent inflammation, immunosuppression, and catabolism syndrome (PICS), have also emerged to characterize prolonged stress responses. For glycaemic management, intensive control offers no outcome benefit and increases hypoglycaemia risk; moderate targets are preferred. Parallel advancements in monitoring techniques, such as indirect calorimetry and body composition analysis, have improved the assessment of the consequences of the metabolic changes. Metabolomics has offered deeper characterisation of the metabolic response to stress and nutrition, highlighting key metabolic pathways and potential therapeutic targets. Integrating biomarkers and metabolomics to define clinical endotypes may help time the transition from catabolic to anabolic strategies and personalize nutrition and pharmacologic support at the bedside. New therapeutic avenues have emerged or are under investigation, including glycaemic control, nutritional strategies, and some specific interventions targeting key components of the metabolic response. In this context, we present a narrative review of the literature with a focus on the clinical consequences of the pathophysiological and metabolic response to stress, alongside therapeutic implications and future perspectives.

**中文摘要译文：**
近年来，对危重症应激反应的理解已显著改善。这些适应性变化在急性期、亚急性期和慢性期展开，包括早期的适应性分解代谢状态、显著的合成代谢抵抗，以及后期向恢复的过渡。本更新综述的目的是总结近期进展，重点关注内分泌、免疫、肠道和线粒体功能的病理生理变化及其对能量产生代谢转变的影响，利用糖酵解以及乳酸和酮体作为替代途径来满足细胞能量需求。对能量消耗和自噬等关键要素理解的进展扩展了我们的知识。此外，人们对强烈且持久的应激反应后果越来越关注，这可能导致ICU获得性衰弱（ICU AW）和重症监护后综合征。近期证据表明，高蛋白策略通常不能改善生存率或功能恢复，并且可能对肾功能不全患者造成伤害，支持谨慎、阶段适宜的蛋白质剂量而非常规高目标。新的概念，如慢性危重症（CCI）和持续性炎症、免疫抑制和分解代谢综合征（PICS），也已出现以描述延长的应激反应。对于血糖管理，强化控制没有提供结局益处并增加低血糖风险；中等目标更受青睐。监测技术的并行进展，如间接测热法和身体成分分析，改善了对代谢变化后果的评估。代谢组学提供了对应激和营养代谢反应的更深入表征，突出了关键代谢途径和潜在治疗靶点。整合生物标志物和代谢组学以定义临床内型可能有助于确定从分解代谢向合成代谢策略过渡的时机，并在床边个性化营养和药物支持。新的治疗途径已经出现或正在研究中，包括血糖控制、营养策略以及一些针对代谢反应关键组成部分的特定干预措施。在此背景下，我们提出一篇叙述性文献综述，重点关注病理生理和代谢应激反应的临床后果，以及治疗意义和未来展望。

### 第二部分 AI 大师评价

本研究通过系统性文献综述方法，深入探讨了危重症应激代谢反应的病理生理机制及其临床意义。研究创新性地整合了内分泌、免疫、肠道和线粒体功能等多维度变化，揭示了糖酵解、乳酸和酮体利用等替代能量代谢途径的重要性。该综述具有重要的临床价值，挑战了传统高蛋白营养策略的有效性，提出了阶段适宜的营养支持理念，并为ICU获得性衰弱和重症监护后综合征的防治提供了新思路。研究局限性在于作为叙述性综述，缺乏原始数据支持，但其对代谢组学与生物标志物整合应用的展望为未来精准医疗在重症监护领域的发展指明了方向。

---

## 3. 半定量PCR检测支气管肺泡灌洗液中耶氏肺孢子菌对HIV阴性免疫功能低下ICU急性呼吸衰竭患者肺炎诊断意义的研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139767](https://pubmed.ncbi.nlm.nih.gov/41139767)
**期刊：** Annals of intensive care
**PMID：** 41139767
**DOI：** 10.1186/s13613-025-01568-3

### 第一部分 原文与翻译

**英文原标题：** Significance of positive semi-quantitative PCR tests on bronchoalveolar lavage for Pneumocystis jirovecii pneumonia in HIV-negative immunocompromised ICU patients with acute respiratory failure.

**英文摘要原文：**
CONTEXT: Real-time PCR (rt-PCR) using cycle threshold (Ct) is a semi-quantitative way to assess DNA amounts, which has become broadly used to diagnose Pneumocystis jirovecii pneumonia (PJP) in non-HIV immunocompromised patients. We aimed to describe the non-HIV immunocompromised patients hospitalized in intensive care unit (ICU) for acute respiratory failure (ARF) and to evaluate the relevance of PJP rt-PCR Ct value in diagnosing PJP. Moreover, the added value of serum 1.3 ß-D-glucan (BDG) assay in this population was also assessed.

METHODS: All non-HIV immunocompromised ICU patients with ARF with at least one rt-PCR performed in broncho-alveolar lavage (BAL) from 2013 to 2023 were retrospectively included. Patients with a positive RT-PCR were classified by reviewers aware of the PCR result, but blinded to Ct values, into confirmed, uncertain, or ruled-out PJP groups based on clinical presentation, imaging findings, organism identification, laboratory results, presence of alternative diagnoses, and the resolution of acute respiratory failure with or without appropriate PJP treatment. PJ rt-PCR Ct and BDG assays of each group were compared. Uncertain diagnoses were excluded from the primary analysis and successively considered as confirmed PJP or ruled-out PJP in a secondary analysis. Using the area under the curve (AUC) of the receiver operating characteristics curves, the best threshold of Ct value was defined.

RESULTS: Out of the 481 non-HIV immunocompromised patients who underwent a PJ rt-PCR in BAL, 59 (12%) had a positive test. The results confirmed PJP for 23/59 (39%), ruled it out for 27/59 (46%), while it remained uncertain for 9/59 (15%). Rt-PCR sensitivity and specificity were respectively 100% (95% CI = [85.7-100%]) and 94% (95% CI = [91.4-95.8%]). Median Ct and BDG levels differed significantly between the confirmed, uncertain, and ruled-out groups at 25, 31, and 34 cycles; and 523, 78, and 32 pg/ml, respectively. The primary analysis identified the best Ct to categorize patients at 30, with an AUC of 0.931 (95% CI [0.850-1.0]), a sensitivity of 86% and a specificity of 89%.

CONCLUSIONS: Semi-quantitative PJ PCR was accurate in diagnosing PJP in non-HIV ICU patients with acute respiratory failure (ARF), and a Ct at low cycle values was more frequent in confirmed PJP than in colonization. The optimal Ct threshold was 30. The BDG assay was especially valuable when high levels were reached.

**中文摘要译文：**
背景：使用循环阈值（Ct）的实时PCR（rt-PCR）是一种评估DNA含量的半定量方法，已广泛应用于非HIV免疫功能低下患者的耶氏肺孢子菌肺炎（PJP）诊断。我们旨在描述因急性呼吸衰竭（ARF）入住重症监护病房（ICU）的非HIV免疫功能低下患者，并评估PJP rt-PCR Ct值在诊断PJP中的相关性。此外，还评估了血清1.3 β-D-葡聚糖（BDG）检测在该人群中的附加价值。

方法：回顾性纳入2013年至2023年间所有因急性呼吸衰竭入住ICU的非HIV免疫功能低下患者，这些患者至少进行过一次支气管肺泡灌洗液（BAL）中的rt-PCR检测。具有阳性RT-PCR结果的患者由知晓PCR结果但对Ct值不知情的评审员根据临床表现、影像学发现、病原体鉴定、实验室结果、替代诊断的存在以及急性呼吸衰竭在有无适当PJP治疗下的缓解情况，分为确诊、不确定或排除PJP组。比较各组的PJ rt-PCR Ct和BDG检测结果。不确定诊断在主要分析中被排除，并在次要分析中依次被视为确诊PJP或排除PJP。使用受试者工作特征曲线下面积（AUC）确定Ct值的最佳阈值。

结果：在接受BAL中PJ rt-PCR检测的481例非HIV免疫功能低下患者中，59例（12%）检测结果为阳性。结果确认23/59例（39%）为PJP，排除27/59例（46%），而9/59例（15%）仍不确定。Rt-PCR的敏感性和特异性分别为100%（95% CI = [85.7-100%]）和94%（95% CI = [91.4-95.8%]）。确诊组、不确定组和排除组的中位Ct和BDG水平存在显著差异，分别为25、31和34个循环；以及523、78和32 pg/ml。主要分析确定最佳Ct分类阈值为30，AUC为0.931（95% CI [0.850-1.0]），敏感性为86%，特异性为89%。

结论：半定量PJ PCR在诊断非HIV ICU急性呼吸衰竭（ARF）患者中的PJP是准确的，低循环值的Ct在确诊PJP中比在定植中更常见。最佳Ct阈值为30。当达到高水平时，BDG检测尤其有价值。

### 第二部分 AI 大师评价

本研究聚焦于非HIV免疫功能低下ICU急性呼吸衰竭患者中耶氏肺孢子菌肺炎（PJP）的诊断挑战，通过回顾性分析481例患者数据，评估了半定量PCR循环阈值（Ct）和血清BDG检测的诊断价值。研究创新性地确定了Ct值30作为最佳诊断阈值，AUC高达0.931，为临床提供了可靠的定量诊断标准。该研究具有重要的临床实践意义，解决了传统PCR检测在定植与感染鉴别中的困境，为重症患者PJP的精准诊断提供了循证依据。然而，研究存在回顾性设计的局限性，且15%的不确定病例比例提示需要更大样本的前瞻性研究进一步验证。

---

## 4. 用于脓毒症免疫状态评估的基因panel开发

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139765](https://pubmed.ncbi.nlm.nih.gov/41139765)
**期刊：** Annals of intensive care
**PMID：** 41139765
**DOI：** 10.1186/s13613-025-01594-1

### 第一部分 原文与翻译

**英文原标题：** Development of a gene panel for immune status assessment in sepsis.

**英文摘要原文：**
BACKGROUND: Sepsis is characterized by a dysregulated immune response to infection, with a balance between hyperinflammation and immunosuppression, which determines the patient's immune status. Real-time monitoring of the immune status in sepsis is crucial for guiding immunotherapy. However, reliable biomarkers are lacking. This study aims to identify a panel of biomarkers for rapid bedside assessment of immune status in sepsis to guide immunotherapy decisions.

RESULTS: TBX21, GNLY, PRF1, and IL2RB represent the immune status in sepsis. These genes demonstrated discriminatory power in the external validation, with area under the curve values ranging from 0.891 to 0.909 across several machine learning models. 99 double-blind randomized patients with sepsis were clustered into two endotypes on the basis of the expression of the four-gene panel. Higher 90-day mortality was observed in patients with sepsis treated with hydrocortisone (Odds ratio 12.46, 95% confidence intervals 3.11 to 65.72) or thymosin (Odds ratio 4.17, 95% confidence intervals 1.13 to 16.51) within the high-expression 4-gene panel endotype, but not in another endotype.

CONCLUSIONS: The results support the potential utility of a four-gene panel to assess immune status and guide immunotherapy; further prospective validation and translational studies are warranted. Trial registration National Medical Research Registration and Filing Information of China, 2022ZDSYLL196-P01. Registered 26 May 2023, https://www.medicalresearch.org.cn/login.

**中文摘要译文：**
背景：脓毒症的特征是对感染的免疫反应失调，在过度炎症和免疫抑制之间保持平衡，这决定了患者的免疫状态。实时监测脓毒症的免疫状态对于指导免疫治疗至关重要。然而，目前缺乏可靠的生物标志物。本研究旨在鉴定一组生物标志物，用于脓毒症免疫状态的快速床旁评估，以指导免疫治疗决策。

结果：TBX21、GNLY、PRF1和IL2RB代表了脓毒症的免疫状态。这些基因在外部验证中表现出区分能力，在多个机器学习模型中曲线下面积值范围为0.891至0.909。基于四基因panel的表达，将99例双盲随机脓毒症患者聚类为两种内型。在高表达四基因panel内型中，接受氢化可的松（比值比12.46，95%置信区间3.11至65.72）或胸腺肽（比值比4.17，95%置信区间1.13至16.51）治疗的脓毒症患者观察到较高的90天死亡率，但在另一内型中未观察到。

结论：结果支持四基因panel在评估免疫状态和指导免疫治疗方面的潜在效用；需要进一步的前瞻性验证和转化研究。试验注册：中国国家医学研究注册与备案信息，2022ZDSYLL196-P01。注册日期：2023年5月26日，https://www.medicalresearch.org.cn/login。

### 第二部分 AI 大师评价

本研究开发了一个基于TBX21、GNLY、PRF1和IL2RB四基因的panel，用于脓毒症患者免疫状态的精准评估。通过机器学习模型验证，该panel展现出优异的区分能力（AUC 0.891-0.909），并能将患者分为不同的免疫内型。创新性地发现，在高表达内型中，氢化可的松和胸腺肽治疗反而增加死亡率，这为脓毒症精准免疫治疗提供了重要依据。该研究具有显著的临床转化价值，但需要更大规模的前瞻性研究进一步验证其临床应用效果。

---

## 5. 致编辑信回复："肾移植受者脓毒症期间免疫抑制治疗管理：一项前瞻性多中心研究"

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139751](https://pubmed.ncbi.nlm.nih.gov/41139751)
**期刊：** Annals of intensive care
**PMID：** 41139751
**DOI：** 10.1186/s13613-025-01599-w

### 第一部分 原文与翻译

**英文原标题：** Response to the Letter to the Editor: "Immunosuppressive therapy management during sepsis in kidney transplant recipients: a prospective multicenter study"

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无摘要可用。

### 第二部分 AI 大师评价

本研究是对先前发表的"肾移植受者脓毒症期间免疫抑制治疗管理：一项前瞻性多中心研究"的编辑来信回复，反映了学术交流的延续性。作为回复性文献，其主要目的是澄清、解释或回应读者对原始研究的疑问和评论。这类文献在学术对话中具有重要价值，能够促进研究结果的准确理解和应用。虽然缺乏详细摘要限制了对其具体内容的深入分析，但此类回复文献对于完善研究透明度、解决争议问题具有积极作用，是高质量学术交流体系的重要组成部分。

---

## 6. 呼吸病毒检测对通气相关性医院获得性肺炎预后的影响：一项暴露/非暴露研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139738](https://pubmed.ncbi.nlm.nih.gov/41139738)
**期刊：** Annals of intensive care
**PMID：** 41139738
**DOI：** 10.1186/s13613-025-01600-6

### 第一部分 原文与翻译

**英文原标题：** Impact of respiratory viruses detection on outcomes in ventilated nosocomial pneumonia: an exposed/unexposed study.

**英文摘要原文：**
INTRODUCTION: Ventilator-associated pneumonia (VAP) and ventilated hospital-acquired pneumonia (vHAP) are major causes of morbidity and mortality in intensive care unit (ICU) patients. The role of viral co-infections in these conditions is an emerging area of interest; however, their impact on clinical outcomes remains poorly understood. This study aimed to assess the effect of viral detection on mortality and other clinical outcomes in patients with bacterial vHAP/VAP.

MATERIALS AND METHODS: We conducted a retrospective analysis of patients diagnosed with bacterial vHAP or VAP in a tertiary ICU between 2020 and 2024. All patients underwent distal respiratory sampling with quantitative culture and multiplex PCR (mPCR) testing for respiratory viruses (Biofire FilmArray Pneumonia Panel). Patients with SARS-CoV-2 infection were excluded. Those with bacterial and viral co-infections were matched 1:1 with patients having bacterial-only vHAP/VAP based on age, sex, SAPS II score, ICU admission cause, and causative bacteria. We compared clinical outcomes, including ICU mortality, 3-month mortality, ICU length of stay, and duration of mechanical ventilation between the two groups.

RESULTS: Eighty patients were included, 40 with bacterial and viral detection and 40 with bacterial-only vHAP/VAP. The median age was 63 years, and 92% of the cohort were male. Common comorbidities included diabetes (25%), heart failure (20%), chronic renal failure (20%), and chronic lung disease (32%). Nineteen percent of patients were immunocompromised. The viral pathogens identified in the co-infection group were rhinovirus/enterovirus 33% (13/40), endemic coronaviruses 30% (12/40), influenza viruses 10% (4/40), parainfluenza viruses 8% (3/10), adenovirus 8% (3/10), metapneumovirus 5% (2/40), and respiratory syncytial virus 5% (2/40). Respiratory viruses were detected in a nasopharyngeal swab in 30% (12/30). The 3-month mortality rate was 36%, ICU mortality was 32%, the median duration of mechanical ventilation was 21 days [IQR 12-31.5], and the median ICU length of stay was 24 days [IQR 13-39.5]. There were no significant differences in these outcomes between the bacterial and viral group and the bacterial-only group.

CONCLUSIONS: In this cohort of patients with bacterial vHAP/VAP, the detection of respiratory viruses did not significantly impact ICU mortality, 3-month mortality, or ICU length of stay. These findings may suggest that bacterial infections are the primary determinants of clinical outcomes in vHAP/VAP.

**中文摘要译文：**
引言：呼吸机相关性肺炎（VAP）和通气相关性医院获得性肺炎（vHAP）是重症监护病房（ICU）患者发病率和死亡率的主要原因。病毒共感染在这些情况中的作用是一个新兴的关注领域；然而，它们对临床结局的影响仍然知之甚少。本研究旨在评估病毒检测对细菌性vHAP/VAP患者死亡率和其他临床结局的影响。

材料与方法：我们对2020年至2024年间在一家三级ICU诊断为细菌性vHAP或VAP的患者进行了回顾性分析。所有患者均接受了远端呼吸道采样，进行定量培养和呼吸道病毒多重PCR（mPCR）检测（Biofire FilmArray Pneumonia Panel）。排除了SARS-CoV-2感染的患者。将细菌和病毒共感染的患者与仅有细菌感染的vHAP/VAP患者按照年龄、性别、SAPS II评分、ICU入院原因和致病细菌进行1:1匹配。我们比较了两组之间的临床结局，包括ICU死亡率、3个月死亡率、ICU住院时间和机械通气持续时间。

结果：共纳入80名患者，其中40名有细菌和病毒检测阳性，40名仅有细菌性vHAP/VAP。中位年龄为63岁，队列中92%为男性。常见的合并症包括糖尿病（25%）、心力衰竭（20%）、慢性肾功能衰竭（20%）和慢性肺病（32%）。19%的患者免疫功能低下。在共感染组中鉴定出的病毒病原体为鼻病毒/肠道病毒33%（13/40）、地方性冠状病毒30%（12/40）、流感病毒10%（4/40）、副流感病毒8%（3/10）、腺病毒8%（3/10）、偏肺病毒5%（2/40）和呼吸道合胞病毒5%（2/40）。30%（12/30）的患者在鼻咽拭子中检测到呼吸道病毒。3个月死亡率为36%，ICU死亡率为32%，机械通气持续时间中位数为21天[IQR 12-31.5]，ICU住院时间中位数为24天[IQR 13-39.5]。这些结局在细菌和病毒组与仅有细菌组之间没有显著差异。

结论：在这组细菌性vHAP/VAP患者中，呼吸道病毒的检测对ICU死亡率、3个月死亡率或ICU住院时间没有显著影响。这些发现可能表明细菌感染是vHAP/VAP临床结局的主要决定因素。

### 第二部分 AI 大师评价

本研究聚焦于呼吸病毒共感染对通气相关性肺炎预后的影响，填补了该领域的重要知识空白。研究采用严谨的回顾性队列设计，通过1:1匹配排除了混杂因素干扰，方法学可靠。关键发现表明病毒共感染并不显著影响ICU死亡率、3个月死亡率等主要临床结局，这一结果挑战了病毒在肺炎预后中的传统认知，具有重要的临床指导价值。然而，研究样本量相对有限，且为单中心回顾性研究，未来需要更大规模的前瞻性研究来验证这些发现，并探索不同病毒种类可能存在的特异性影响。

---

## 7. 危重症肌病中独特的昼夜体温节律模式：两项前瞻性试验的二次分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41139729](https://pubmed.ncbi.nlm.nih.gov/41139729)
**期刊：** Annals of intensive care
**PMID：** 41139729
**DOI：** 10.1186/s13613-025-01582-5

### 第一部分 原文与翻译

**英文原标题：** Distinct diurnal temperature rhythm patterns in critical illness myopathy: secondary analysis of two prospective trials.

**英文摘要原文：**
BACKGROUND: Critical illness myopathy (CIM) increases mortality and causes long-term disabilities. CIM is characterized by reduced muscle excitability, muscle atrophy, weakness, and impaired glucose metabolism. Functional circadian rhythms are important for skeletal muscle homeostasis. Circadian rhythms are often disrupted during critical illness in the Intensive Care Unit (ICU). This analysis investigates whether diurnal temperature rhythms differ in critically ill CIM compared to no-CIM patients.

METHODS: This is a secondary analysis of two prospective trials including critically ill patients with CIM (n = 32) or no-CIM (n = 30) based on electrophysiological tests. Diurnal body temperature rhythms were compared between CIM and no-CIM groups in reference to n = 16 participants included in a bed rest study. Cosinor analysis was performed to determine the rhythm parameters and classify into rhythm classes. Aggregated and longitudinal data were compared between groups using non-parametric tests. Rhythm parameters were correlated with muscle atrophy, weakness and insulin sensitivity.

RESULTS: CIM and no-CIM patients had severe multiorgan failure (median SOFA score 12 in both groups, p = 0.39). The temperature rhythm nadir timepoint was shifted in CIM patients (10:43 [09:21, 12:22]) and no-CIM (11:12 [09:43, 13:30]) compared to the healthy bed rest group (5:03 [3:22, 6:36]) p < 0.001. CIM patients showed lower temperature rhythm mesors than no-CIM patients (p = 0.041). The temperature rhythm amplitude was lower in both CIM and no-CIM patients compared to the healthy bed rest group (CIM: 0.3 °C [0.2, 0.4]; no-CIM: 0.2 °C [0.2, 0.3]; healthy bed rest: 0.5 °C [0.2, 0.6]; p < 0.01). Compared to no-CIM patients, CIM patients had higher temperature rhythm amplitudes (p = 0.021) and showed a less pronounced reduction in temperature rhythm amplitudes during ICU stay (p = 0.017). A higher temperature rhythm amplitude correlated negatively with M. vastus lateralis myocyte cross-sectional area.

CONCLUSIONS: Heterogeneous phase shifts of diurnal temperature rhythms in CIM and no-CIM groups compared to healthy bed rest volunteers may indicate ICU-related circadian disruption. Suppression of temperature rhythm amplitude during ICU stay could represent an adaptive response to this disruption. Blunted amplitude suppression observed in CIM compared to no-CIM patients might reflect reduced adaptation, potentially contributing to muscle catabolism. This hypothesis-generating analysis underlines the need for mechanistic studies exploring circadian regulation in skeletal muscle during critical illness.

**中文摘要译文：**
背景：危重症肌病（CIM）会增加死亡率并导致长期残疾。CIM的特征包括肌肉兴奋性降低、肌肉萎缩、无力以及葡萄糖代谢受损。功能性昼夜节律对骨骼肌稳态至关重要。在重症监护病房（ICU）的危重症期间，昼夜节律常常被破坏。本分析旨在探讨危重症CIM患者与非CIM患者的昼夜体温节律是否存在差异。

方法：这是对两项前瞻性试验的二次分析，纳入基于电生理学检查诊断为CIM（n=32）或非CIM（n=30）的危重症患者。将CIM组和非CIM组的昼夜体温节律与卧床休息研究中纳入的n=16名参与者进行比较。采用余弦分析确定节律参数并进行节律分类。使用非参数检验比较组间的汇总数据和纵向数据。将节律参数与肌肉萎缩、无力和胰岛素敏感性进行相关性分析。

结果：CIM和非CIM患者均存在严重多器官功能衰竭（两组中位SOFA评分均为12，p=0.39）。与健康卧床休息组（5:03 [3:22, 6:36]）相比，CIM患者（10:43 [09:21, 12:22]）和非CIM患者（11:12 [09:43, 13:30]）的体温节律最低点时间发生偏移（p<0.001）。CIM患者的体温节律中值低于非CIM患者（p=0.041）。与健康卧床休息组相比，CIM和非CIM患者的体温节律振幅均较低（CIM：0.3°C [0.2, 0.4]；非CIM：0.2°C [0.2, 0.3]；健康卧床休息：0.5°C [0.2, 0.6]；p<0.01）。与非CIM患者相比，CIM患者的体温节律振幅更高（p=0.021），且在ICU住院期间体温节律振幅的下降程度较不明显（p=0.017）。较高的体温节律振幅与股外侧肌肌细胞横截面积呈负相关。

结论：与健康卧床休息志愿者相比，CIM组和非CIM组中昼夜体温节律的异质性相位偏移可能表明ICU相关的昼夜节律紊乱。ICU住院期间体温节律振幅的抑制可能代表对这种紊乱的适应性反应。与非CIM患者相比，CIM患者观察到的振幅抑制减弱可能反映了适应能力降低，可能促进肌肉分解代谢。这一假设生成性分析强调了探索危重症期间骨骼肌昼夜节律调节机制研究的必要性。

### 第二部分 AI 大师评价

本研究通过二次分析探讨了危重症肌病患者昼夜体温节律的特征差异，具有重要的创新性。研究采用前瞻性试验数据，结合余弦分析和非参数统计方法，系统比较了CIM、非CIM患者与健康对照组的节律参数。关键发现显示CIM患者存在独特的体温节律模式，包括更高的节律振幅和减弱的振幅抑制，这可能反映了机体对ICU环境适应能力的差异。该研究首次将昼夜节律紊乱与危重症肌病的病理生理机制联系起来，为理解CIM的发生发展提供了新的视角，具有重要的临床价值。然而作为二次分析，研究存在样本量有限等局限性，需要更大规模的机制研究来验证这些发现。

---

## 8. 脂筏蛋白质组学鉴定内皮肌球蛋白-9（MYH9）为低密度脂蛋白跨胞转运和动脉粥样硬化的调节因子

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41134623](https://pubmed.ncbi.nlm.nih.gov/41134623)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41134623
**DOI：** 10.1073/pnas.2509315122

### 第一部分 原文与翻译

**英文原标题：** Lipid raft proteomics identify endothelial myosin-9 (MYH9) as a regulator of low-density lipoprotein transcytosis and atherosclerosis.

**英文摘要原文：**
BACKGROUND: In early atherosclerosis, circulating Low-Density Lipoprotein (LDL) crosses the endothelium by transcytosis. This involves caveolar uptake of LDL by scavenger receptor BI (SR-BI) and activin-like kinase 1 (ALK1) and requires the protein caveolin-1 (Cav-1). We identified mediators of LDL transcytosis by isolating membrane microdomains enriched in caveolin-1 from human coronary endothelial cells (HCAECs) treated with LDL and performing mass spectrometry. One of the proteins identified was myosin-9 (MYH9).

METHODS: Total internal reflection fluorescence microscopy was conducted to measure LDL transcytosis by HCAECs. We measured LDL transcytosis in vivo in mice lacking endothelial MYH9 (EC-). Atherosclerosis studies were also performed in EC- deleted of hepatic LDLR via (adeno-associated virus, AAV)-CRISPR. Additionally, we performed analysis of human transcriptomic data.

RESULTS: Gene ontology analysis in human aortic endothelial cells suggested a role for MYH9 in exocytosis. Both knockdown and pharmacologic inhibition of MYH9 inhibited LDL transcytosis. MYH9 depletion caused an accumulation of LDL-containing vesicles at the base of the cell; overexpression caused an increase in LDL exocytosis. EC- mice accumulated less LDL in the aortic arch after acute injection with LDL. To investigate the role of MYH9 in atherosclerosis, we deleted hepatic LDL in EC- mice using AAV-CRISPR and fed them a high-fat diet. The aortic arch and root of AAV-CRISPR; EC- mice exhibited smaller plaques. Human transcriptomic data showed greater messenger RNA (mRNA) levels of aortic  in atherosclerotic aortas compared to healthy controls.

CONCLUSIONS: Lipid raft proteomics identified MYH9 as a regulator of LDL transcytosis. MYH9 is required for endothelial LDL exocytosis and contributes to early atherosclerosis.

**中文摘要译文：**
背景：在早期动脉粥样硬化中，循环低密度脂蛋白（LDL）通过跨胞转运穿过内皮。这一过程涉及通过清道夫受体BI（SR-BI）和激活素样激酶1（ALK1）对小窝摄取LDL，并且需要蛋白caveolin-1（Cav-1）。我们通过从经LDL处理的人冠状动脉内皮细胞（HCAECs）中分离富含caveolin-1的膜微区并进行质谱分析，鉴定了LDL跨胞转运的介质。鉴定出的蛋白之一是肌球蛋白-9（MYH9）。

方法：采用全内反射荧光显微镜测量HCAECs的LDL跨胞转运。我们在缺乏内皮MYH9（EC-）的小鼠体内测量了LDL跨胞转运。还通过（腺相关病毒，AAV）-CRISPR在缺失肝LDLR的EC-小鼠中进行了动脉粥样硬化研究。此外，我们分析了人类转录组数据。

结果：人主动脉内皮细胞中的基因本体分析提示MYH9在外泌作用中发挥作用。MYH9的敲低和药理学抑制均抑制了LDL跨胞转运。MYH9耗竭导致含LDL的囊泡在细胞基部积聚；过表达导致LDL外泌增加。EC-小鼠在急性注射LDL后主动脉弓中积累的LDL较少。为了研究MYH9在动脉粥样硬化中的作用，我们使用AAV-CRISPR删除了EC-小鼠的肝LDL，并给它们喂食高脂饮食。AAV-CRISPR; EC-小鼠的主动脉弓和根部表现出较小的斑块。人类转录组数据显示，与健康对照相比，动脉粥样硬化主动脉中主动脉的信使RNA（mRNA）水平更高。

结论：脂筏蛋白质组学鉴定MYH9为LDL跨胞转运的调节因子。MYH9是内皮LDL外泌所必需的，并有助于早期动脉粥样硬化。

### 第二部分 AI 大师评价

本研究通过脂筏蛋白质组学方法系统性地揭示了MYH9在LDL跨胞转运和动脉粥样硬化发生中的关键作用。研究团队采用多层次的实验策略，包括细胞水平的蛋白质组学筛选、体外功能验证、动物模型体内实验以及人类转录组数据分析，展现了严谨的研究设计。该研究的创新性在于首次将MYH9这一细胞骨架蛋白与脂质跨内皮转运机制联系起来，为理解动脉粥样硬化的早期发病机制提供了新的分子视角。这一发现具有重要的临床转化价值，可能为开发针对早期动脉粥样硬化的新型治疗靶点奠定基础。不过，研究主要聚焦于早期病变阶段，对于MYH9在晚期斑块进展中的具体作用仍需进一步探索。

---

## 9. 单细胞测序揭示感觉神经元介导的CGRP信号通路是肉瘤进展的驱动因素

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41118222](https://pubmed.ncbi.nlm.nih.gov/41118222)
**期刊：** Proceedings of the National Academy of Sciences of the United States of America
**PMID：** 41118222
**DOI：** 10.1073/pnas.2500161122

### 第一部分 原文与翻译

**英文原标题：** Single-cell sequencing uncovers sensory neuron-mediated CGRP signaling as a driver of sarcoma progression.

**英文摘要原文：**
Bone pain is a presenting feature of bone cancers such as osteosarcoma (OS), relayed by skeletal-innervating peripheral afferent neurons. Potential functions of tumor-associated sensory neurons in bone cancers beyond pain sensation are unknown. To uncover neural regulatory functions, a chemical-genetic approach in mice with a knock-in allele for TrkA was used to functionally perturb sensory nerve innervation during OS growth and disease progression. TrkA inhibition in transgenic mice led to significant reductions in sarcoma-associated sensory innervation and vascularization, skewed tumor associated macrophage polarization, reduced tumor growth and metastasis, and prolonged overall survival. Single-cell transcriptomics revealed that sarcoma denervation was associated with phenotypic alterations in both OS tumor cells and cells within the tumor microenvironment, and with reduced calcitonin gene-related peptide (CGRP) and vascular endothelial growth factor (VEGF) signaling. Multimodal and multiomics analyses of human OS bone samples further implicated peripheral innervation and neurotrophin signaling in OS tumor biology. Next and in two parallel approaches to inhibit nerve ingrowth, we repurposed FDA-approved bupivacaine liposomes and separately blocked CGRP signaling using FDA-approved Rimegepant. Both strategies led to significant reductions in sarcoma growth, vascularity, and sarcoma-induced hyperalgesia. In sum, TrkA-expressing peripheral neurons positively regulate key aspects of OS progression and sensory neural inhibition disrupts CGRP signaling within the sarcoma microenvironment leading to significantly reduced tumor growth and improved survival. These data suggest that interventions to prevent pathological innervation of OS represent an adjunctive therapy to improve clinical outcomes and survival.

**中文摘要译文：**
骨痛是骨癌（如骨肉瘤）的一个临床表现特征，由骨骼支配的外周传入神经元传递。肿瘤相关感觉神经元在骨癌中除了疼痛感知之外的潜在功能尚不清楚。为了揭示神经调节功能，我们在具有TrkA敲入等位基因的小鼠中使用化学遗传学方法，在骨肉瘤生长和疾病进展过程中功能性地干扰感觉神经支配。转基因小鼠中TrkA抑制导致肉瘤相关感觉神经支配和血管化显著减少，肿瘤相关巨噬细胞极化偏向，肿瘤生长和转移减少，以及总生存期延长。单细胞转录组学显示，肉瘤去神经支配与骨肉瘤肿瘤细胞和肿瘤微环境内细胞的表型改变相关，并与降钙素基因相关肽（CGRP）和血管内皮生长因子（VEGF）信号传导减少相关。对人类骨肉瘤骨样本的多模式和多组学分析进一步表明外周神经支配和神经营养因子信号传导在骨肉瘤肿瘤生物学中的作用。接下来，在两种抑制神经向内生长的平行方法中，我们重新利用了FDA批准的布比卡因脂质体，并分别使用FDA批准的Rimegepant阻断CGRP信号传导。两种策略均导致肉瘤生长、血管化和肉瘤诱导的痛觉过敏显著减少。总之，表达TrkA的外周神经元正向调节骨肉瘤进展的关键方面，感觉神经抑制破坏了肉瘤微环境中的CGRP信号传导，导致肿瘤生长显著减少和生存改善。这些数据表明，预防骨肉瘤病理性神经支配的干预措施代表了一种改善临床结果和生存的辅助疗法。

### 第二部分 AI 大师评价

本研究通过创新的化学遗传学方法揭示了感觉神经元在骨肉瘤进展中的关键调控作用。研究核心发现是TrkA表达的感觉神经元通过介导CGRP信号通路，正向调控骨肉瘤的生长、血管化和转移。该研究的创新性在于首次系统阐明了神经-肿瘤相互作用机制，并验证了两种FDA批准药物（布比卡因脂质体和Rimegepant）作为神经干预策略的有效性。这一发现具有重要的临床转化价值，为骨肉瘤治疗提供了新的辅助治疗靶点，但研究主要基于动物模型，需要在人类临床试验中进一步验证其安全性和有效性。

---

速递结束，祝您工作愉快！